EU Commission Authorises Eaton's Use Of Chromium Trioxide

The European Commission has announced a crucial decision under the Regulation (EC) No 1907/2006, commonly known as REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals). The decision, documented as C/2023/1180, was published in accordance with Article 64(9) of the REACH regulation and holds critical implications for industries and stakeholders engaged in the usage of certain chemical substances.

Key Highlights Of The Decision

Date of Decision: November 22, 2023Substance: Chromium trioxide (EC No. 215-607-8, CAS No. 1333-82-0)Authorisation Holders and Uses:Eaton S.R.L., Italy and Eaton Automotive Systems sp.zoo, Poland - Authorised for functional chrome plating of engine valves and valve actuation (‘lash adjusters’), with the authorisation number REACH/23/25/0, valid until December 31, 2030.

Rationale For The Decision

The European Commission, in its decision, has carefully weighed the socio-economic benefits against the potential risks to human health and the environment. The decision to grant authorisation for the use of Chromium trioxide is anchored in the finding that the socio-economic advantages significantly overshadow the risks. Furthermore, the Commission concluded that there are no suitable alternative substances or technologies available that could replace the use of Chromium trioxide in these specific applications.

Implications And Actions For Stakeholders

This decision underscores the Commission's commitment to ensuring a balance between economic activities and environmental and health protection. For stakeholders, particularly in the automotive industry, this decision provides a clear regulatory framework and operational certainty until the end of 2030.

However, it is imperative for authorised entities to adhere strictly to the conditions of the authorisation. They must ensure that all safety measures are in place to mitigate any health or environmental risks. Additionally, the ongoing search for safer alternatives should remain a priority, in line with REACH's ultimate goal of ensuring a high level of protection for human health and the environment.